Company Filing History:
Years Active: 2023-2024
Title: Renata Jankowska: Innovator in Antibacterial Pharmaceutical Compositions
Introduction
Renata Jankowska is a prominent inventor based in Edmonton, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. With a total of two patents to her name, her work focuses on innovative solutions for bacterial infections.
Latest Patents
Renata's latest patents include "Pharmaceutical compositions comprising LTV-17 and beta-lactamase inhibitors and their use as antibacterial agents." This patent provides combinations of LTV-17, a lactivicin derivative, and β-lactamase inhibitors, which are designed to treat or prevent bacterial infections. Another notable patent is "Lactivicin compounds, their preparation and use as antibacterial agents." This patent details lactivicin compounds and their pharmaceutically acceptable salts, which serve as antibiotics suitable for use alone or in combination with other antibiotics in the treatment of bacterial infections.
Career Highlights
Renata Jankowska is currently associated with Fedora Pharmaceuticals Inc., where she continues to advance her research in antibacterial agents. Her work has been instrumental in developing new pharmaceutical compositions that address the growing concern of antibiotic resistance.
Collaborations
Renata collaborates with esteemed colleagues, including Sameeh M Salama and Samarendra N Maiti. These partnerships enhance her research efforts and contribute to the innovative solutions being developed at Fedora Pharmaceuticals Inc.
Conclusion
Renata Jankowska's contributions to the field of pharmaceuticals, particularly in antibacterial agents, highlight her role as a leading inventor. Her patents reflect her commitment to addressing critical health challenges through innovative research and development.